1/7
01:37 am
adxn
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia [Yahoo! Finance]
Low
Report
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia [Yahoo! Finance]
1/7
01:00 am
adxn
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
Low
Report
Addex Spin-Out Neurosterix has started a Phase 1 Clinical Study with M4 PAM - NTX-253 for Schizophrenia
12/11
01:00 am
adxn
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
High
Report
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
12/4
07:03 pm
adxn
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... [Yahoo! Finance]
Medium
Report
Addex Therapeutics Ltd (ADXN) Q3 2025 Earnings Call Highlights: Strategic Advances Amidst ... [Yahoo! Finance]
12/4
01:00 am
adxn
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
Low
Report
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
12/1
01:19 am
adxn
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025 [Yahoo! Finance]
Medium
Report
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025 [Yahoo! Finance]
12/1
01:00 am
adxn
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
Medium
Report
Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host Conference Call on December 4, 2025
10/29
02:00 am
adxn
Addex Increases Issued Share Capital to Create Treasury Shares
Low
Report
Addex Increases Issued Share Capital to Create Treasury Shares